To establish the 4-nitroquinoline 1-oxide (4-NQO) model, female, immunocompetent C57BL/6J mice aged 8 weeks were purchased from Jackson Laboratories. Protocols for animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) under the reference #18042580. To induce the development of oral carcinomas, mice were administered the carcinogen 4-NQO (Tokyo Chemical Industry CO., LTD.) in drinking water once a week. Therefore, 4-NQO was dissolved in propylene glycol (Sigma-Aldrich) as stock solution (4 mg/mL), which was immediately diluted to a concentration of 0.1 mg/mL in the drinking water. 4-NQO was protected from light at all times. Mice were treated with 4-NQO for 16 weeks followed by the provision of normal drinking water.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.